Focusing on exosomes to overcome the existing bottlenecks of CAR-T cell therapy

Abstract Since chimeric antigen receptor T (CAR-T) cells were introduced three decades ago, the treatment using these cells has led to outstanding outcomes, and at the moment, CAR-T cell therapy is a well-established mainstay for treating CD19 + malignancies and multiple myeloma. Despite the astonis...

Full description

Saved in:
Bibliographic Details
Main Authors: Si-Heng Zhang (Author), Ling-Long Peng (Author), Yi-Fei Chen (Author), Yan Xu (Author), Vahid Moradi (Author)
Format: Book
Published: BMC, 2024-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available